On October 12, Elon Musk’s brain-computer interface company Neuralink announced a major advancement in its technology. According to the company, Nick Wray, a patient diagnosed with amyotrophic lateral sclerosis (ALS) — commonly known as “Lou Gehrig’s disease” — has successfully used a brain implant to control a robotic arm through thought alone, completing multiple daily tasks independently.
Using Neuralink’s brain-computer interface system, Wray was able to precisely grasp a cup and drink from it, open a refrigerator, use a microwave to heat food, and put on a hat — everyday actions that represent a profound step toward restoring autonomy for people with severe motor impairments.
The core of the technology lies in a brain-implanted chip capable of decoding neural signals in real time and wirelessly transmitting them via Bluetooth to external devices, enabling seamless thought-based control.
This demonstration is part of Neuralink’s “CONVOY” clinical research program, approved by the U.S. Food and Drug Administration (FDA). Wray is the eighth participant to receive the experimental implant. Neuralink began its first human trials in 2024, following the resolution of significant safety concerns raised by the FDA in 2022.
The company’s first implant recipient, Noland Arbaugh, previously demonstrated the ability to control a computer cursor and play video games using only his thoughts. Wray’s case extends these capabilities from the digital realm into the physical world, showing the potential for real-world assistance in daily living.
Beyond household tasks, Wray also achieved a record performance in a dexterity test originally designed for stroke patients, moving 39 cylinders within five minutes. Remarkably, he also managed to control his wheelchair using the Neuralink interface and even completed what he called an “unbelievable trick shot” with the robotic arm.
Neuralink’s progress underscores the growing promise of brain-computer interface technology in enhancing quality of life and independence for people with severe neurological conditions.